NBSENeuBase Therapeutics, Inc.

Nasdaq neubasetherapeutics.com


$ 0.44 $ 0.02 (4.99 %)    

Tuesday, 23-Apr-2024 15:23:12 EDT
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 0.442
$ 0.44
$ 0.41 x 100
$ 0.00 x 0
$ 0.44 - $ 0.44
$ 0.39 - $ 4.80
25,441
na
741,419
$ 1.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-09-2023 09-30-2023 10-Q
2 08-14-2023 06-30-2023 10-Q
3 05-11-2023 03-31-2023 10-Q
4 02-14-2023 12-31-2022 10-Q
5 12-21-2022 09-30-2022 10-K
6 08-11-2022 06-30-2022 10-Q
7 05-12-2022 03-31-2022 10-Q
8 02-11-2022 12-31-2021 10-Q
9 12-23-2021 09-30-2021 10-K
10 08-13-2021 06-30-2021 10-Q
11 05-14-2021 03-31-2021 10-Q
12 02-11-2021 12-31-2020 10-Q
13 12-23-2020 09-30-2020 10-K
14 08-13-2020 06-30-2020 10-Q
15 05-14-2020 03-31-2020 10-Q
16 03-26-2020 12-31-2019 10-Q
17 01-10-2020 09-30-2019 10-K
18 08-14-2019 06-30-2019 10-Q
19 05-15-2019 03-31-2019 10-Q
20 02-14-2019 12-31-2018 10-Q
21 01-03-2019 09-30-2018 10-K
22 08-14-2018 06-30-2018 10-Q
23 05-15-2018 03-31-2018 10-Q
24 02-14-2018 12-31-2017 10-Q
25 12-15-2017 09-30-2017 10-K
26 08-08-2017 06-30-2017 10-Q
27 05-11-2017 03-31-2017 10-Q
28 02-14-2017 12-31-2016 10-Q
29 12-22-2016 09-30-2016 10-K
30 08-09-2016 06-30-2016 10-Q
31 05-10-2016 03-31-2016 10-Q
32 02-09-2016 12-31-2015 10-Q
33 12-14-2015 09-30-2015 10-K
34 08-06-2015 06-30-2015 10-Q
35 05-11-2015 03-31-2015 10-Q
36 02-09-2015 12-31-2014 10-Q
37 12-22-2014 09-30-2014 10-K
38 08-18-2014 06-30-2014 10-Q
39 05-13-2014 03-31-2014 10-Q
40 02-14-2014 12-31-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 neubase-therapeutics-received-a-notice--on-april-4-2024-from-the-listing-qualifications-department-of-the-nasdaq-stock-market-notifying-the-company-that-it-was-not-in-compliance-with-nasdaqs-continued-listing-requirements-under-nasdaq-listing-rule-5250c1

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice ...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 nasdaq-gains-over-50-points-us-durable-goods-orders-rise-in-february

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% t...

 why-stoke-therapeutics-shares-are-trading-higher-by-around-70-here-are-20-stocks-moving-premarket

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase...

 why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

 why-intuitive-machines-shares-are-trading-lower-by-around-30-here-are-20-stocks-moving-premarket

Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Fr...

 neubase-therapeutics-on-feb-22-board-determined-for-company-to-dissolve-liquidate-and-distribute-to-stockholders-its-available-assets-has-been-engaged-in-evaluation-of-potential-strategic-and-other-alternatives

-SEC Filing

 neubase-therapeutics-filed-prospectus-supplement-related-to-offering-of-up-to-10m-of-shares-of-common-stock

-424B3   https://www.sec.gov/Archives/edgar/data/1173281/000110465923129848/tm2333795d1_424b3.htm

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION